• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产生甲胎蛋白的Xp11易位性肾细胞癌:病例报告及文献复习

AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.

作者信息

Zhang Hui-Zhi, Wang Su-Ying

机构信息

Department of Pathology, Ningbo Diagnostic Pathology Center, Ningbo, Zhejiang, China.

Department of Pathology, Ningbo Diagnostic Pathology Center, Ningbo, Zhejiang, China.

出版信息

Curr Probl Cancer. 2021 Jun;45(3):100689. doi: 10.1016/j.currproblcancer.2020.100689. Epub 2020 Dec 29.

DOI:10.1016/j.currproblcancer.2020.100689
PMID:33388149
Abstract

Alpha-fetoprotein (AFP) is a useful tumor marker for hepatocellular carcinomas and yolk sac tumors. Rare extrahepatic visceral malignancies may be associated with AFP production and those exhibiting a hepatoid differentiation by morphology and immunohistochemical are classified as hepatoid adenocarcinoma. Renal cell carcinoma (RCC) producing AFP is a rare entity. To date, only one case of AFP-producing Xp11 translocation RCC has been reported. We reported another case of Xp11 translocation RCC, in which the tumor cells displayed strong immunostaining for AFP, HepPar1, and GPC-3. Additionally, the other published cases are reviewed.

摘要

甲胎蛋白(AFP)是肝细胞癌和卵黄囊瘤的一种有用的肿瘤标志物。罕见的肝外内脏恶性肿瘤可能与AFP产生有关,那些在形态学和免疫组织化学上表现出肝样分化的肿瘤被归类为肝样腺癌。产生AFP的肾细胞癌(RCC)是一种罕见的实体。迄今为止,仅报道过1例产生AFP的Xp11易位性RCC。我们报告了另一例Xp11易位性RCC,其中肿瘤细胞对AFP、HepPar1和GPC-3呈强免疫染色。此外,还对其他已发表的病例进行了回顾。

相似文献

1
AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature.产生甲胎蛋白的Xp11易位性肾细胞癌:病例报告及文献复习
Curr Probl Cancer. 2021 Jun;45(3):100689. doi: 10.1016/j.currproblcancer.2020.100689. Epub 2020 Dec 29.
2
Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance.肾细胞癌中的肝样分化:一种具有临床意义的罕见组织学模式。
Ann Diagn Pathol. 2014 Dec;18(6):363-8. doi: 10.1016/j.anndiagpath.2014.10.004. Epub 2014 Oct 13.
3
Renal cell carcinoma producing alpha-fetoprotein (AFP) with a unique lectins-affinity profile.产生甲胎蛋白(AFP)且具有独特凝集素亲和力特征的肾细胞癌。
J Surg Oncol. 1994 Apr;55(4):215-21. doi: 10.1002/jso.2930550404.
4
Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.肾盂产甲胎蛋白癌,具有肝样和尿路上皮分化。
Anticancer Res. 2012 Nov;32(11):4987-91.
5
Alpha-fetoprotein-producing renal cell carcinoma.
Urol Int. 2001;67(2):181-3. doi: 10.1159/000050982.
6
Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene.Xp11.2 易位性肾肿瘤,具有 TFE3 重排相关肾细胞癌和 Xp11 易位性肾间叶肿瘤伴黑色素细胞分化特征,携带 NONO-TFE3 融合基因。
Pathol Res Pract. 2019 Sep;215(9):152521. doi: 10.1016/j.prp.2019.152521. Epub 2019 Jun 27.
7
TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.TFE3 断裂分离 FISH 检测与 TFE3 或组织蛋白酶 K 免疫组化染色单独检测相比,对 Xp11.2 易位相关性肾细胞癌具有更高的敏感性:扩大形态学谱。
Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.
8
[A case of renal cell carcinoma producing alpha-fetoprotein].一例产生甲胎蛋白的肾细胞癌
Hinyokika Kiyo. 2001 Jul;47(7):477-80.
9
A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.一例与长期透析相关的双侧肾细胞癌,表现为TFE3假阳性免疫反应,诊断为Xp11易位性肾细胞癌。
Int J Clin Exp Pathol. 2013 Oct 15;6(11):2585-90. eCollection 2013.
10
Alpha-fetoprotein-producing renal cell carcinoma.
Cancer. 1988 Jan 1;61(1):84-8. doi: 10.1002/1097-0142(19880101)61:1<84::aid-cncr2820610114>3.0.co;2-i.

引用本文的文献

1
Machine learning-based multiparametric CT radiomics for predicting microvascular invasion before nephrectomy in clear cell renal cell carcinoma.基于机器学习的多参数CT影像组学在预测透明细胞肾细胞癌肾切除术前微血管侵犯中的应用
Abdom Radiol (NY). 2025 Apr 18. doi: 10.1007/s00261-025-04956-2.
2
Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.除了肝癌,甲胎蛋白在临床实践中还有更多的应用场景。
Front Oncol. 2023 Sep 15;13:1231420. doi: 10.3389/fonc.2023.1231420. eCollection 2023.
3
A simple and available measurement of onco-sEV dsDNA to protein ratio as a potential tumor marker.
一种简单可行的肿瘤标志物——onc-sEV dsDNA 与蛋白比值的测量方法。
BMC Cancer. 2023 Jul 3;23(1):614. doi: 10.1186/s12885-023-10886-3.
4
Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of Bone Metastasis in Renal Cell Carcinoma Patients.基于大数据的肾癌患者骨转移风险预测的机器学习预测模型的建立与验证。
Comput Math Methods Med. 2022 Oct 3;2022:5676570. doi: 10.1155/2022/5676570. eCollection 2022.
5
Profiling of Serum Extracellular Vesicles Reveals as a Potential Biomarker for Advanced Renal Cell Carcinoma.血清外泌体分析显示[标志物名称]是晚期肾细胞癌的潜在生物标志物。
Cancer Genomics Proteomics. 2021 May-Jun;18(3):253-259. doi: 10.21873/cgp.20256.
6
Time-varying effects of FOXA1 on breast cancer prognosis.FOXA1 对乳腺癌预后的时变影响。
Breast Cancer Res Treat. 2021 Jun;187(3):867-875. doi: 10.1007/s10549-021-06125-7. Epub 2021 Feb 18.